Literature DB >> 28003490

Lineage A Betacoronavirus NS2 Proteins and the Homologous Torovirus Berne pp1a Carboxy-Terminal Domain Are Phosphodiesterases That Antagonize Activation of RNase L.

Stephen A Goldstein1, Joshua M Thornbrough1, Rong Zhang1, Babal K Jha2, Yize Li1, Ruth Elliott1, Katherine Quiroz-Figueroa1, Annie I Chen1, Robert H Silverman2, Susan R Weiss3.   

Abstract

Viruses in the family Coronaviridae, within the order Nidovirales, are etiologic agents of a range of human and animal diseases, including both mild and severe respiratory diseases in humans. These viruses encode conserved replicase and structural proteins as well as more diverse accessory proteins, encoded in the 3' ends of their genomes, that often act as host cell antagonists. We previously showed that 2',5'-phosphodiesterases (2',5'-PDEs) encoded by the prototypical Betacoronavirus, mouse hepatitis virus (MHV), and by Middle East respiratory syndrome-associated coronavirus antagonize the oligoadenylate-RNase L (OAS-RNase L) pathway. Here we report that additional coronavirus superfamily members, including lineage A betacoronaviruses and toroviruses infecting both humans and animals, encode 2',5'-PDEs capable of antagonizing RNase L. We used a chimeric MHV system (MHVMut) in which exogenous PDEs were expressed from an MHV backbone lacking the gene for a functional NS2 protein, the endogenous RNase L antagonist. With this system, we found that 2',5'-PDEs encoded by the human coronavirus HCoV-OC43 (OC43; an agent of the common cold), human enteric coronavirus (HECoV), equine coronavirus (ECoV), and equine torovirus Berne (BEV) are enzymatically active, rescue replication of MHVMut in bone marrow-derived macrophages, and inhibit RNase L-mediated rRNA degradation in these cells. Additionally, PDEs encoded by OC43 and BEV rescue MHVMut replication and restore pathogenesis in wild-type (WT) B6 mice. This finding expands the range of viruses known to encode antagonists of the potent OAS-RNase L antiviral pathway, highlighting its importance in a range of species as well as the selective pressures exerted on viruses to antagonize it.IMPORTANCE Viruses in the family Coronaviridae include important human and animal pathogens, including the recently emerged viruses severe acute respiratory syndrome-associated coronavirus (SARS-CoV) and Middle East respiratory syndrome-associated coronavirus (MERS-CoV). We showed previously that two viruses within the genus Betacoronavirus, mouse hepatitis virus (MHV) and MERS-CoV, encode 2',5'-phosphodiesterases (2',5'-PDEs) that antagonize the OAS-RNase L pathway, and we report here that these proteins are furthermore conserved among additional coronavirus superfamily members, including lineage A betacoronaviruses and toroviruses, suggesting that they may play critical roles in pathogenesis. As there are no licensed vaccines or effective antivirals against human coronaviruses and few against those infecting animals, identifying viral proteins contributing to virulence can inform therapeutic development. Thus, this work demonstrates that a potent antagonist of host antiviral defenses is encoded by multiple and diverse viruses within the family Coronaviridae, presenting a possible broad-spectrum therapeutic target.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  RNase L; interferon antagonist; lineage A coronavirus; oligoadenylate synthetase; phosphodiesterase; torovirus

Mesh:

Substances:

Year:  2017        PMID: 28003490      PMCID: PMC5309944          DOI: 10.1128/JVI.02201-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.

Authors:  Chandar S Thakur; Zan Xu; Zhengfu Wang; Zachary Novince; Robert H Silverman
Journal:  Methods Mol Med       Date:  2005

Review 2.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

3.  Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS.

Authors:  E Ontiveros; L Kuo; P S Masters; S Perlman
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

4.  Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal.

Authors:  J L Gombold; S T Hingley; S R Weiss
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors.

Authors:  P Sheffield; S Garrard; Z Derewenda
Journal:  Protein Expr Purif       Date:  1999-02       Impact factor: 1.650

Review 6.  SARS: lessons learned from other coronaviruses.

Authors:  Sonia Navas-Martin; Susan R Weiss
Journal:  Viral Immunol       Date:  2003       Impact factor: 2.257

7.  Detection of novel members, structure-function analysis and evolutionary classification of the 2H phosphoesterase superfamily.

Authors:  Raja Mazumder; Lakshminarayan M Iyer; Sona Vasudevan; L Aravind
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

8.  The carboxyl-terminal part of the putative Berne virus polymerase is expressed by ribosomal frameshifting and contains sequence motifs which indicate that toro- and coronaviruses are evolutionarily related.

Authors:  E J Snijder; J A den Boon; P J Bredenbeek; M C Horzinek; R Rijnbrand; W J Spaan
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

9.  Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.

Authors:  Eric J Snijder; Peter J Bredenbeek; Jessika C Dobbe; Volker Thiel; John Ziebuhr; Leo L M Poon; Yi Guan; Mikhail Rozanov; Willy J M Spaan; Alexander E Gorbalenya
Journal:  J Mol Biol       Date:  2003-08-29       Impact factor: 5.469

10.  Detection of Severe Acute Respiratory Syndrome-Like, Middle East Respiratory Syndrome-Like Bat Coronaviruses and Group H Rotavirus in Faeces of Korean Bats.

Authors:  H K Kim; S-W Yoon; D-J Kim; B-S Koo; J Y Noh; J H Kim; Y G Choi; W Na; K-T Chang; D Song; D G Jeong
Journal:  Transbound Emerg Dis       Date:  2016-05-23       Impact factor: 5.005

View more
  13 in total

1.  Zika Virus Production Is Resistant to RNase L Antiviral Activity.

Authors:  Jillian N Whelan; Yize Li; Robert H Silverman; Susan R Weiss
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

2.  MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells.

Authors:  Courtney E Comar; Clayton J Otter; Jessica Pfannenstiel; Ethan Doerger; David M Renner; Li Hui Tan; Stanley Perlman; Noam A Cohen; Anthony R Fehr; Susan R Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-20       Impact factor: 12.779

3.  SARS-CoV-2 diverges from other betacoronaviruses in only partially activating the IRE1α/XBP1 ER stress pathway in human lung-derived cells.

Authors:  Long C Nguyen; David M Renner; Diane Silva; Dongbo Yang; Nicholas Parenti; Kaeri M Medina; Vlad Nicolaescu; Haley Gula; Nir Drayman; Andrea Valdespino; Adil Mohamed; Christopher Dann; Kristin Wannemo; Lydia Robinson-Mailman; Alan Gonzalez; Letícia Stock; Mengrui Cao; Zeyu Qiao; Raymond E Moellering; Savas Tay; Glenn Randall; Michael F Beers; Marsha Rich Rosner; Scott A Oakes; Susan R Weiss
Journal:  bioRxiv       Date:  2022-06-13

4.  Zika virus employs the host antiviral RNase L protein to support replication factory assembly.

Authors:  Jillian N Whelan; Nicholas A Parenti; Joshua Hatterschide; David M Renner; Yize Li; Hanako M Reyes; Beihua Dong; Erick R Perez; Robert H Silverman; Susan R Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

5.  Rapid RNase L-driven arrest of protein synthesis in the dsRNA response without degradation of translation machinery.

Authors:  Jesse Donovan; Sneha Rath; David Kolet-Mandrikov; Alexei Korennykh
Journal:  RNA       Date:  2017-08-14       Impact factor: 4.942

6.  A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates.

Authors:  Sean M Cascarina; Eric D Ross
Journal:  FASEB J       Date:  2020-06-20       Impact factor: 5.191

7.  Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection.

Authors:  Courtney E Comar; Stephen A Goldstein; Yize Li; Boyd Yount; Ralph S Baric; Susan R Weiss
Journal:  mBio       Date:  2019-03-26       Impact factor: 7.867

8.  A prenylated dsRNA sensor protects against severe COVID-19.

Authors:  Elena Sugrue; Spyros Lytras; Srikeerthana Kuchi; Marko Noerenberg; Matthew L Turnbull; Arthur Wickenhagen; Colin Loney; Vanessa Herder; Jay Allan; Innes Jarmson; Natalia Cameron-Ruiz; Margus Varjak; Rute M Pinto; Jeffrey Y Lee; Louisa Iselin; Natasha Palmalux; Douglas G Stewart; Simon Swingler; Edward J D Greenwood; Thomas W M Crozier; Quan Gu; Emma L Davies; Sara Clohisey; Bo Wang; Fabio Trindade Maranhão Costa; Monique Freire Santana; Luiz Carlos de Lima Ferreira; Lee Murphy; Angie Fawkes; Alison Meynert; Graeme Grimes; Joao Luiz Da Silva Filho; Matthias Marti; Joseph Hughes; Richard J Stanton; Eddie C Y Wang; Antonia Ho; Ilan Davis; Ruth F Jarrett; Alfredo Castello; David L Robertson; Malcolm G Semple; Peter J M Openshaw; Massimo Palmarini; Paul J Lehner; J Kenneth Baillie; Suzannah J Rihn; Sam J Wilson
Journal:  Science       Date:  2021-10-29       Impact factor: 63.714

Review 9.  Functions of Coronavirus Accessory Proteins: Overview of the State of the Art.

Authors:  Puxian Fang; Liurong Fang; Huichang Zhang; Sijin Xia; Shaobo Xiao
Journal:  Viruses       Date:  2021-06-13       Impact factor: 5.048

Review 10.  Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.

Authors:  Thomas Kehrer; Adolfo García-Sastre; Lisa Miorin
Journal:  J Interferon Cytokine Res       Date:  2021-06       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.